SPC
LLY icon

Spirepoint Private Client’s Eli Lilly LLY Stock Holding History

Spirepoint Private Client’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Buy
20,170
+264
+1% +$270K 1.96% 14
2026
Q1 		$18.3M Buy
19,906
+956
+5% +$969K 1.74% 13
2025
Q4 		$20.4M Buy
18,950
+2,098
+12% +$2.01M 1.95% 12
2025
Q3 		$12.9M Buy
16,852
+696
+4% +$518K 1.35% 17
2025
Q2 		$12.6M Buy
16,156
+384
+2% +$298K 1.42% 16
2025
Q1 		$13M Buy
15,772
+657
+4% +$547K 1.7% 14
2024
Q4 		$11.7M Buy
15,115
+1,115
+8% +$923K 1.46% 17
2024
Q3 		$12.4M Sell
14,000
-175
-1% -$157K 1.64% 13
2024
Q2 		$12.8M Buy
14,175
+1,854
+15% +$1.48M 1.82% 12
2024
Q1 		$9.59M Buy
+12,321
New +$8.77M 1.46% 14

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Spirepoint Private Client's LLY Position: Q2 2026 in Review

Spirepoint Private Client increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $270K and bringing the position to 20,170 shares worth $24.2M. The position accounts for 1.96% of the portfolio, ranked #14.

Spirepoint Private Client first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Spirepoint Private Client held 20,170 shares of Eli Lilly worth $24.2M as of Q2 2026.
  • Spirepoint Private Client bought 264 Eli Lilly shares in Q2 2026, an estimated $270K.
  • Eli Lilly made up 1.96% of Spirepoint Private Client's portfolio in Q2 2026, its #14 holding.
  • Spirepoint Private Client first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.